1. Reflections on NICE’s Uptake of New Methods: Past, Present, and the 2020 Review

   • Meindert Boysen
   • Ian Watson

   Commentary 04 February 2020 Pages: 243 - 245

2. After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?

   • Mark Sculpher
   • Stephen Palmer

   Current Opinion 13 January 2020 Pages: 247 - 257

3. Challenges of Systematic Reviews of Economic Evaluations: A Review of Recent Reviews and an Obesity Case Study

   • Elisabet Jacobsen
   • Dwayne Boyers
   • Alison Avenell

   Practical Application Open access 13 January 2020 Pages: 259 - 267

4. Multi-criteria Decision Analysis Software in Healthcare Priority Setting: A Systematic Review

   • Alexander Moreno-Calderón
   • Thai S. Tong
   • Praveen Thokala

   Systematic Review 10 December 2019 Pages: 269 - 283

   

5. Potential Bias Associated with Modeling the Effectiveness of Healthcare Interventions in Reducing Mortality Using an Overall Hazard Ratio

   • Fernando Alarid-Escudero
   • Karen M. Kuntz

   Original Research Article 22 November 2019 Pages: 285 - 296

   

6. Healthcare Expenditures for the Treatment of Patients Infected with Hepatitis C Virus in Japan

   • Haruhisa Fukuda
   • Yoshihiko Yano
   • Osamu Takahashi

   Original Research Article 25 November 2019 Pages: 297 - 306

7. Economic Impact of Early-in-Hospital Diagnosis and Initiation of Eculizumab in Atypical Haemolytic Uraemic Syndrome

   • Michael Ryan
   • Bonnie M. K. Donato
   • Jeffrey Laurence

   Original Research Article Open access 12 December 2019 Pages: 307 - 313

   

8. Correction to: The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary Syndromes

   • Laura Panattoni
   • Paul M. Brown
   • Patrick Gladding

   Correction 21 January 2020 Pages: 315 - 315